Delivery Order SPE2DB25D7056-SPE2DB25FTMND

Award Date 6/5/25
Potential Completion Date 6/6/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a Delivery Order valued at $2,432.95 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tenofovir Disoproxil Fumarate 300 mg tablets, with an ultimate completion date of May 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $7,044.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB20D7066|SPE2DB25FC3GH) for the supply of 4,568,192,545 units of Tenofovir Disoproxil Fumarate 300 mg tablets. The contract has a firm fixed price and is set to expire on May 12, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $2,374.83 firm fixed price delivery order is for the supply of 4,564,136 units of Tenofovir Disoproxil Fumarate 300 mg tablets. The award has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,811.22 Firm Fixed Price Delivery Order is for the supply of Tenofovir Disoproxil Fumarate 300 mg tablets. This contract is not set aside for any small business designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,777.32, is for the delivery of Tenofovir Disoproxil Fumarate 300 mg tablets. The award is not designated as a set-aside contract. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $47,350.48, is for the delivery of emtricitabine-tenofovir 200-300 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of November 30, 2023. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,267.59, is a Delivery Order for the procurement of Emtricitabine-Tenofovir 200-300 mg medication. It is a Firm Fixed Price contract with a completion date of March 7, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of Tenofovir Disoproxil Fumarate 300 mg tablets to the Defense Logistics Agency (DLA). The single-award Indefinite Delivery Contract (IDC) with a ceiling value of $2,374.83 was issued to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract has a firm-fixed price pricing structure and an ultimate completion date of July 16, 2024. This IDC serves as the primary vehicle for Amerisourcebergen to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,187.91, is a delivery order for the supply of emtricitabine-tenofovir 200-300 mg tablets. The contract has an ultimate completion date of February 18, 2025 and uses a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,453.35, is for the delivery of emtricitabine-tenofovir 200-300 mg medications. The contract is a delivery order and has a firm fixed price pricing type, with a completion date of December 30, 2024. This award is not associated with a set-aside designation. AmerisourceBergen holds a significant...
  • SPE2DB25D7056
    Indefinite Delivery Contract
  • SPE2DB25D7056-SPE2DB25FTMND
    Delivery Order

This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract, valued at $1,974.41, is a Firm Fixed Price Delivery Order for the supply of Tenofovir Disoproxil Fumarate 300 mg tablets. The contract has a completion date of June 6, 2025 and is not designated as a set-aside.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/4/25, 9:57 AM